PDF

Type 1 and Type 2 Diabetes Nephropathy Study

TBD

Category
Page
Record History
Added on September 25, 2017 at 8:20 AM by Kimber, Jessica
Modified on September 26, 2017 at 8:00 AM by Kimber, Jessica
Shared with (contributions)
DRTC: Clinical Trials Master

Type 1 and Type 2 Diabetes Nephropathy Study

The purpose of this study is to determine study drug effectiveness in the treatment of diabetic nephropathy.

 

To qualify to participate:

  • be 21 years to 80 years of age

  • Have documented diabetic nephropathy with either Type 1 or Type 2 diabetes

  • stable blood pressure

  • BMI less than or equal to 45 kg/m2

 

How to Participate

To participate, contact Jonathan Williams at (615) 875-9200 or e-mail at jonathan.m.williams@vanderbilt.edu